Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 9 studies | 20% ± 4% | |
pericyte | 8 studies | 20% ± 7% | |
endothelial cell | 8 studies | 24% ± 7% | |
plasmacytoid dendritic cell | 7 studies | 25% ± 7% | |
glutamatergic neuron | 5 studies | 27% ± 10% | |
retinal cone cell | 5 studies | 29% ± 8% | |
macrophage | 5 studies | 24% ± 6% | |
non-classical monocyte | 3 studies | 25% ± 5% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 21% ± 1% | |
classical monocyte | 3 studies | 26% ± 8% | |
hematopoietic precursor cell | 3 studies | 18% ± 1% | |
retinal bipolar neuron | 3 studies | 18% ± 1% | |
microglial cell | 3 studies | 20% ± 1% | |
myeloid cell | 3 studies | 25% ± 4% | |
epithelial cell | 3 studies | 28% ± 7% | |
retinal rod cell | 3 studies | 17% ± 1% | |
fibroblast | 3 studies | 18% ± 2% | |
goblet cell | 3 studies | 26% ± 7% | |
astrocyte | 3 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 6053.85 | 359 / 359 | 100% | 42.27 | 286 / 286 |
skin | 100% | 6904.78 | 1808 / 1809 | 100% | 69.01 | 472 / 472 |
ovary | 100% | 10001.98 | 180 / 180 | 100% | 38.65 | 429 / 430 |
thymus | 100% | 6550.51 | 652 / 653 | 100% | 46.41 | 604 / 605 |
prostate | 100% | 8090.22 | 244 / 245 | 100% | 51.92 | 502 / 502 |
adrenal gland | 100% | 7334.03 | 258 / 258 | 100% | 52.63 | 229 / 230 |
uterus | 100% | 11923.22 | 170 / 170 | 100% | 37.55 | 457 / 459 |
breast | 100% | 7377.55 | 459 / 459 | 99% | 57.92 | 1112 / 1118 |
lung | 100% | 9067.01 | 578 / 578 | 99% | 42.94 | 1147 / 1155 |
intestine | 100% | 9462.45 | 966 / 966 | 99% | 35.20 | 523 / 527 |
esophagus | 100% | 8296.00 | 1440 / 1445 | 99% | 46.45 | 182 / 183 |
bladder | 100% | 8794.24 | 21 / 21 | 98% | 28.59 | 493 / 504 |
pancreas | 98% | 3363.14 | 322 / 328 | 99% | 43.43 | 176 / 178 |
kidney | 99% | 4065.19 | 88 / 89 | 98% | 40.55 | 882 / 901 |
brain | 92% | 6065.63 | 2442 / 2642 | 100% | 40.29 | 703 / 705 |
liver | 77% | 1864.70 | 174 / 226 | 98% | 27.84 | 397 / 406 |
adipose | 100% | 7967.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 16557.34 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 47.07 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 45.95 | 29 / 29 |
muscle | 100% | 22510.57 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7107.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.01 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.02 | 1 / 1 |
heart | 99% | 7882.10 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 4773.29 | 861 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0002062 | Biological process | chondrocyte differentiation |
GO_0001958 | Biological process | endochondral ossification |
GO_0030154 | Biological process | cell differentiation |
GO_0007512 | Biological process | adult heart development |
GO_0007517 | Biological process | muscle organ development |
GO_0006915 | Biological process | apoptotic process |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_0007399 | Biological process | nervous system development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | MEF2D |
Protein name | Myocyte enhancer factor 2D Myocyte-specific enhancer factor 2D MEF2D variant protein MEF2D protein (Myocyte enhancer factor 2D) |
Synonyms | protein variant |
Description | FUNCTION: Transcriptional activator which binds specifically to the MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle-specific, growth factor- and stress-induced genes. Mediates cellular functions not only in skeletal and cardiac muscle development, but also in neuronal differentiation and survival. Plays diverse roles in the control of cell growth, survival and apoptosis via p38 MAPK signaling in muscle-specific and/or growth factor-related transcription. Plays a critical role in the regulation of neuronal apoptosis (By similarity). . |
Accessions | Q4LE66 ENST00000475587.2 A0A0G2JLL8 ENST00000348159.9 [Q14814-1] ENST00000464356.6 [Q14814-5] ENST00000708597.1 [Q14814-4] Q05BX2 Q14814 ENST00000708596.1 [Q14814-1] ENST00000489057.1 ENST00000360595.7 [Q14814-4] ENST00000708595.1 [Q14814-5] |